Cargando…
PROLONGED, PROFOUND UNTREATED HYPOXIA IN COVID-19 ARDS WITH REFUSAL OF TREATMENT
Autores principales: | THOMAS, KALEB, KRUTSINGER, DUSTIN |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Chest Physicians. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503118/ http://dx.doi.org/10.1016/j.chest.2021.07.814 |
Ejemplares similares
-
NEUROMUSCULAR BLOCKING AGENT BUNDLES IN THE MEDICAL ICU TO PREVENT PROLONGED USE OF PARALYTICS IN PATIENTS WITH COVID-19-RELATED ARDS
por: PINCHOVER, ZACHARY S, et al.
Publicado: (2022) -
LUCINACTANT, A SYNTHETIC SURFACTANT FOR TREATMENT OF COVID-19-ASSOCIATED ARDS
por: GUARDIA, CARLOS G, et al.
Publicado: (2022) -
EARLY GAS EXCHANGE PARAMETERS NOT ASSOCIATED WITH SURVIVAL IN COVID-19-ASSOCIATED ARDS PATIENTS REQUIRING PROLONGED VENOVENOUS EXTRACORPOREAL MEMBRANE OXYGENATION
por: DAVIS, ANDREW J., et al.
Publicado: (2022) -
MANAGEMENT OF PNEUMOTHORAX AND PNEUMOMEDIASTINUM IN COVID-19 PATIENTS WITH ARDS
por: BAKER, COLBY M., et al.
Publicado: (2022) -
PROVIDER EXPERIENCE WITH PRONE POSITIONING FOR ARDS DURING COVID-19
por: HOCHBERG, CHAD, et al.
Publicado: (2021)